EG244495 Inhibitors
EG244495 inhibitors are a class of chemical compounds designed to selectively block the function of the **EG244495** protein, a molecular entity likely involved in critical cellular processes such as enzymatic activity, intracellular signaling, or molecular transport. These inhibitors work by binding to key regulatory or active sites on EG244495, effectively preventing it from engaging in its normal biological functions within the cell. By doing so, they disrupt the protein's role in maintaining cellular homeostasis, allowing researchers to examine how the inhibition of EG244495 affects broader biochemical pathways. Inhibiting this protein provides insights into its contribution to processes such as protein turnover, molecular communication, or energy regulation, offering a window into the mechanisms that govern cellular behavior.
The use of EG244495 inhibitors plays a crucial role in research aimed at understanding how this protein interacts with other molecules and systems within the cell. By observing the consequences of blocking EG244495, scientists can uncover the downstream effects of its inhibition on cellular pathways, revealing its importance in regulating molecular networks. Additionally, these inhibitors provide a means to study compensatory mechanisms or alternative pathways that cells might activate in response to the loss of EG244495 function. This helps researchers map out the interconnected roles of proteins in maintaining cellular balance. Overall, EG244495 inhibitors serve as valuable tools in molecular biology, offering a detailed view of the interactions and functions that sustain key cellular processes, and helping to uncover the precise role of this protein in complex biological systems.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
AZD1152-HQPA | 722544-51-6 | sc-265334 | 10 mg | $375.00 | ||
Aurora B kinase inhibitor impacting Sgo2b's involvement in mitotic sister chromatid segregation. AZD1152 disrupts Aurora B kinase activity, influencing Sgo2b's function at the centromeric region, leading to the inhibition of mitotic sister chromatid segregation. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
PP2A inhibitor impacting Sgo2b's involvement in meiotic sister chromatid cohesion. Okadaic Acid disrupts PP2A activity, influencing Sgo2b's function in nuclear bodies and inhibiting meiotic sister chromatid cohesion. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
Aurora B kinase inhibitor influencing Sgo2b's participation in mitotic sister chromatid segregation. ZM447439 disrupts Aurora B kinase activity, modulating Sgo2b's role at the centromeric region, leading to the inhibition of mitotic sister chromatid segregation. | ||||||
CDC25 Phosphatase Inhibitor II, NSC 663284 | 383907-43-5 | sc-202987A sc-202987 sc-202987B sc-202987C | 1 mg 5 mg 10 mg 25 mg | $51.00 $241.00 $357.00 $663.00 | 4 | |
PLK1 inhibitor affecting Sgo2b's role in meiotic sister chromatid cohesion. NSC 663284 disrupts PLK1 activity, influencing Sgo2b's function in nuclear bodies and inhibiting meiotic sister chromatid cohesion. | ||||||
BI 2536 | 755038-02-9 | sc-364431 sc-364431A | 5 mg 50 mg | $151.00 $525.00 | 8 | |
PLK1 inhibitor impacting Sgo2b's involvement in mitotic sister chromatid segregation. BI 2536 disrupts PLK1 activity, modulating Sgo2b's role at the centromeric region, leading to the inhibition of mitotic sister chromatid segregation. | ||||||
GSK 923295 | 1088965-37-0 | sc-490136 | 5 mg | $290.00 | ||
Aurora A kinase inhibitor influencing Sgo2b's participation in mitotic sister chromatid segregation. GSK923295 disrupts Aurora A kinase activity, modulating Sgo2b's function at the centromeric region, leading to the inhibition of mitotic sister chromatid segregation. | ||||||
S-Trityl-L-cysteine | 2799-07-7 | sc-202799 sc-202799A | 1 g 5 g | $32.00 $66.00 | 6 | |
Eg5 inhibitor affecting Sgo2b's role in meiotic sister chromatid cohesion. S-Trityl-L-cysteine disrupts Eg5 activity, influencing Sgo2b's function in nuclear bodies and inhibiting meiotic sister chromatid cohesion. | ||||||
MLN 8054 | 869363-13-3 | sc-484828 | 5 mg | $398.00 | ||
Aurora A kinase inhibitor impacting Sgo2b's involvement in mitotic sister chromatid segregation. MLN8054 disrupts Aurora A kinase activity, modulating Sgo2b's role at the centromeric region, leading to the inhibition of mitotic sister chromatid segregation. | ||||||
Tozasertib | 639089-54-6 | sc-358750 sc-358750A | 25 mg 50 mg | $62.00 $87.00 | 4 | |
Aurora A and B kinase inhibitor affecting Sgo2b's role in mitotic sister chromatid segregation. VX-680 disrupts both Aurora A and B kinase activities, modulating Sgo2b's functions at the centromeric region, leading to the inhibition of mitotic sister chromatid segregation. | ||||||
Polo-like Kinase Inhibitor III | 660868-91-7 | sc-203202 | 500 µg | $109.00 | 1 | |
PLK1 inhibitor impacting Sgo2b's involvement in meiotic sister chromatid cohesion. GW843682X disrupts PLK1 activity, modulating Sgo2b's function in nuclear bodies and inhibiting meiotic sister chromatid cohesion. | ||||||